Two physicians received a total of $500,000 in grants from the Heart Rhythm Society (HRS) and Boehringer Ingelheim Pharmaceuticals to support quality improvement research on atrial fibrillation and stroke prevention.
Mark H. Eckman, MD, of the University of Cincinnati, and Steven A. Lubitz, MD, MPH, of Massachusetts General Hospital, were awarded the atrial fibrillation quality improvement innovation grant on May 6 at the HRS scientific sessions in San Francisco.
HRS received 35 applications for the contest, which included quality demonstration projects and research focused on improving risk screening and management of adults with non-valvular atrial fibrillation who are at risk for ischemic stroke. Six finalists presented at the HRS scientific sessions on May 5.
Eckman’s research is titled “Shared Decision-Making Tool for Thromboprophylaxis in Atrial Fibrillation,” while Lubitz’s research is titled “Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation.”
Eckman and Lubitz will present their findings at the 2017 HRS scientific sessions in Chicago.